诚信认证：
工商注册信息已核实！
快速导航
产品分类
微信二维码
Minisite
QQ号咨询
催化和无机化学
Dorsomorphin
| 品牌 | 厂商性质 | 产地 | 货期 |
|---|---|---|---|
| 阿拉丁 | 生产商 | 上海 | 现货 |
产品参数
| 货号 | CAS号 | 价格（元） | 操作 |
|---|---|---|---|
| D139352-100mg | 866405-64-3 | 4799 | 询价 |
| D139352-25mg | 866405-64-3 | 1399 | 询价 |
| D139352-5mg | 866405-64-3 | 469 | 询价 |
产品介绍
- 分子式 C24H25N5O
- 分子量399.49
- Beilstein号
- EC号
- MDL号 MFCD08705402
- PubChem编号
属性
| 敏感性 | 对光及空气敏感 |
| 溶解性 | Soluble in DMSO (4 mg/ml warm), 100 mM HCl, and MeOH. |
| 存贮条件 | 储存温度2-8℃ |
描述
| 应用 | A potent inhibitor of AMPK and fatty acid biosynthesis. |
| 产品介绍 | BML-275 is a cell-permeable pyrazolopyrimidine compound shown to be an AMP-activated protein kinase (AMPK) and Fatty Acid Synthase inhibitor. Phosphorylation of AMPK occurs in vivo when energy sources are low and in-turn suppresses expression of SREBP-1. SREBP-1 is a key lipogenic transcription factor, and its suppression allows glucose production by hepatocytes. In mouse studies it has been reported that BML-275 rapidly reduces the level of the phosphorylated AMPK α subunit in the hypothalamus, in an ATP-competitive manner, therefore altering energy perception and affecting the physiological energy sensor of the body. Over-activation of AMPK has also been found to be deleterious in ischemic stroke conditions and inhibition of AMPK by BML-275 may provide a small level of neuroprotection. Additional research on zebrafish has shown that BML-275 also inhibits bone morphogenetic protein signals required for iron metabolism and embryogenesis. BML-275 is an inhibitor of ACTR-I, BMPR-IA and BMPR-IB. |
| 生化机理 | Dorsomorphin is a selective inhibitor of Bone morphogenetic protein (BMP) signaling. It has been found to inhibit BMP signals required for embryogenesis and promoted significant neural differentiation from human pluripotent stem cell (hPSC) lines. Dorsomorphin also acts as a potent, selective, reversible, and ATP-competitive inhibitor of AMPK (AMP-activated protein kinase); Ki = 109 nM in the presence of 5 μM ATP and the absence of AMP). |
| 别名 | 6-[4-[2-(1-哌啶基)乙氧基]苯基]-3-(4-吡啶基)吡唑并[1,5-a]嘧啶;AMPK 抑制剂;BML-275;6-[4-(2-Piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine; AMPK Inhibitor;Compound C;BML-275 |
Dorsomorphin信息由上海阿拉丁生化科技股份有限公司为您提供，如您想了解更多关于Dorsomorphin报价、型号、参数等信息，欢迎来电或留言咨询。
注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途